Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
Leukemia Research|January 1, 1986
Conversion of acute undifferentiated leukemia phenotypes: analysis of clonal developmentA Raghavachar, C R Bartram, G Gaedicke, et al.Journal of Perinatal Medicine|January 1, 1986
Placental transfer of parathyroid hormoneS Balabanova, T Lang, A S Wolf, et al.British Journal of Haematology|January 29, 2000
Dominant beta-thalassaemia: a highly unstable haemoglobin is caused by a novel 6 bp deletion of the beta-globin geneB Vetter, G Neu-Yilik, E Kohne, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapyU Pertl, A D Luster, N M Varki, et al.Cancer Letters|July 26, 2003
Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastomaB Lange, U Schroeder, N Huebener, et al.European Journal of Pediatrics|August 1, 1986
Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D)T Becker, E Küenzlen, A Salama, et al.European Journal of Pediatrics|April 1, 1997
Paediatric thrombo-embolism: the influence of non-genetic factors and the role of activated protein C resistance and protein C deficiencyM M Uttenreuther-Fischer, B Vetter, C Hellmann, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1974
Induction of endogenous virus and of thymidine kinase by bromodeoxyuridine in cell cultures transformed by Friend virusW Ostertag, G Roesler, C J Krieg, et al.Cancer Letters|July 26, 2003
Neuroblastoma directed therapy by a rational prodrug design of etoposide as a substrate for tyrosine hydroxylaseJ Jikai, M Shamis, N Huebener, et al.Cancer Letters|July 26, 2003
Vaccination with minigenes encoding for novel 'self' antigens are effective in DNA-vaccination against neuroblastomaN Huebener, B Lange, C Lemmel, et al.Pageof 10